Condensed Consolidated Statements of Operations (USD $) In Thousands, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Revenues	$ 528	$ 338	$ 1,664	$ 1,206
Cost of revenues	324	236	799	830
Gross profit	204	102	865	376
Sales and marketing expenses	217	231	838	812
General and administrative expenses	830	835	2,451	2,971
Research and development costs	481	465	1,311	1,166
Operating Loss	(1,324)	(1,429)	(3,735)	(4,573)
Loss on extinguishment of debt			0	(6,006)
Gain (loss) from change in fair value of hybrid financial instruments	17,631	(6,941)	4,203	12,611
Gain (loss) from change in fair value of derivative liability - warrants	568	(1,105)	2,263	9,751
Gain (loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	43,727	(15,561)	12,457	31,263
Interest expense related to convertible debt	(1,155)	(595)	(2,812)	(1,551)
Net Income (loss)	59,447	(25,631)	12,376	41,495
Dividends on convertible preferred stock			0	(2,500)
Net Income attributable to common shareholders			12,376	38,995
Comprehensive income (loss):
Net Income	59,447	(25,631)	12,376	41,495
Other comprehensive loss - foreign currency translation adjustment	(19)	23	(32)	(27)
Comprehensive Income (loss)	$ 59,428	$ (25,608)	$ 12,344	$ 41,468
Net income (loss) per share, basic and diluted:
Basic (in dollars per share)	$ 0.26	$ (1.13)	$ 0.13	$ 1.74
Fully diluted (in dollars per share)	$ 0	$ (1.13)	$ 0	$ (0.02)
Weighted average number of common shares:
Basic (in shares)	226,839,514	22,678,877	97,493,073	22,470,014
Fully diluted (in shares)	3,440,185,503	22,678,877	3,222,207,099	301,266,858